Pharmaceutical IP and competition law in South Africa: overview
Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to pharmaceutical IP and competition law in South Africa.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
To read the full Q&A, visit Thomson Reuters Practical Law.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.
New South African Plant Breeders’ Rights law comes into effect
South Africa’s new Plant Breeders’ Rights Act 12 of 2018 (new Act) has, by proclamation in the Government Gazette of 6 June 2025, been deemed to have been in effect since 1 June 2025. Thus, the Pl...
June 09 2025
Summary of Aspen v Adcock [2025] 017055-25
The case of Aspen Pharmacare Holdings Group & Pharmacare Limited v Adcock Ingram Healthcare (Pty) Ltd & Adcock Ingram Intellectual (Pty) Ltd, was recently heard in the High Court and judgment ...
May 13 2025
Africa's Hidden Treasures: The WIPO Treaty Revolution
The African continent boasts a wealth of biodiversity and is a treasure trove of genetic resources and traditional knowledge. These valuable assets have long been a source of innovation and inspiratio...
May 06 2025